The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Share News (BMY)

Share Price Information for Bloomsbury (BMY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 568.00
Bid: 566.00
Ask: 572.00
Change: -2.00 (-0.35%)
Spread: 6.00 (1.06%)
Open: 564.00
High: 568.00
Low: 564.00
Prev. Close: 570.00
BMY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: Riverstone Credit stays stable, Bloomsbury hails record half

Thu, 26th Oct 2023 18:12

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Wednesday and Thursday, and not separately reported by Alliance News:

----------

Riverstone Credit Opportunities Income PLC - London-based energy infrastructure and energy transition credit investor - Net asset value at September 30 was USD1.07, unchanged from June 30. Says this stability was due to continued strong portfolio performance during the third quarter of 2023, and that as of September 30 it is nearly fully invested based on the revolving credit facility added in the fourth quarter last year and on current portfolio commitments. Riverstone Credit says it remains extremely well positioned due to its portfolio of accredited energy-transition focused investments through green or sustainability-linked structured loans. Notes "backdrop of strong energy market performance, the global focus on decarbonisation and the company's unique focus on short duration lending."

----------

Bloomsbury Publishing PLC - London-based publisher - Pretax profit for the half year ended August 31 was up 8% to GBP14.0 million from GBP12.9 million the year before. Says revenue increased 11% to GBP136.7 million from GBP122.9 million, and diluted earnings per share rose 11% to 13.66 pence from 12.30p. Consumer revenue grew 17% to GBP89.4 million, Adult Trade revenue rose 8% to GBP27.6 million and Children's Trade revenue grew 22% to GBP61.7 million. Declares interim dividend of 3.70p per share, more than double 1.41p the prior year. Cash at August 31 totalled GBP39.1 million, down from GBP41.5 million on the same day in 2022. Says it is confident it will achieve market expectations for the year ending February 29 2024, meaning revenue of GBP273.1 million and profit before tax and "highlighted items" of GBP32.5 million.

----------

Schroder Income Growth Fund PLC - UK-based investment company - Lifts dividend for the year ended August 31 by 4.6% to 13.80p per share from 13.20p the year before. Net asset value total return was positive 4.2%, underperforming against positive 5.2% from the FTSE All Share Total Return index. NAV per share decreased to 293.58p from 295.26p. Says many challenges "look set to continue into the year ahead."

----------

Haydale Graphene Industries PLC - Carmarthenshire, Wales-based technology solutions company - Pretax loss for the year ended June 30 widens to GBP6.6 million compared with GBP5.2 million the previous year. Revenue increased 48% to GBP4.3 million from GBP2.9 million, with US sales continuing to progress on "growth in the core aerospace and automotive markets". Administrative expenses increased 13% to GBP6.3 million from GBP5.5 million. Non-Executive Chair David Banks says: "We have made important progress in our next planned steps as a business by forging commercial partnerships and collaborations with leading organisations...the board remains confident that the company will be able to take advantage of the traction it is now seeing."

----------

e-Therapeutics PLC - Oxford, England-based computer-based drug discovery company - Says that in six months ended July 31, pretax loss widened to GBP6.6 million from GBP4.5 million the previous year. Revenue fell 46% to GBP160,000 from GBP295,000. Chief Executive Officer Ali Mortazavi says: "Despite a severe macroeconomic climate, we have made significant progress during the past six months...we have been able to translate our computational analyses into tangible assets, generating compelling preclinical data at a fraction of the R&D spend of any competitor." Research & development expenditure increased to GBP5.3 million from GBP3.1 million. Company expects higher "underlying cash burn" in the current half year due to its "planned increase in R&D spend to continue the expansion of our AI capabilities and progress the identification and execution of preclinical targets, together with sustaining our active IP strategy as novel inventions are generated."

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
19 Mar 2019 11:35

Bloomsbury Publishing ends year in line with expectations

(Sharecast News) - Bloomsbury Publishing issued a pre-close trading update for the 12 months ended 28 February on Tuesday, saying it expected results for the year to be in line with the board's expectations.

Read more
24 Jan 2019 15:09

Thursday broker round-up

(Sharecast News) - Reckitt Benckiser: Jefferies downgrades to underperform with a target price of 5,000p.

Read more
7 Jan 2019 09:02

Bloomsbury Publishing Inks Two Digital Distribution Partnerships

LONDON (Alliance News) - Bloomsbury Publishing PLC said Monday it has partnered with Rowman & Littlefield and Manchester University Press to sell their digital titles.Under the the will

Read more
23 Oct 2018 11:00

WINNERS & LOSERS SUMMARY: Travis Perkins Rises After Strong Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 3.8%, Randgold Resources, a

Read more
23 Oct 2018 10:20

Bloomsbury grows underlying profit as adult books fly off shelves

(Sharecast News) - Bloomsbury Publishing grew underlying profits 13% in the first half of its financial year as revenues were boosted by books by Kamila Shamsie, Anthony Bourdain and continued sales of 'Harry Potter' books.

Read more
23 Oct 2018 09:28

Bloomsbury Publishing Hikes Interim Payout On Broad-Based Sales Rise

LONDON (Alliance News) - Harry Potter-publisher Bloomsbury Publishing PLC boosted its interim dividend Tuesday after revenue rose despite reported profit dipping on one-off costs.For the to

Read more
19 Jul 2018 16:16

UK Dividends Calendar - Next 7 Days

Friday 20 July Air Partnerdividend payment dateTelford Homesdividend payment payment 23

Read more
1 Jun 2018 17:38

DIRECTOR DEALINGS: Bloomsbury Publishing Chief Executive Sells Shares

LONDON (Alliance News) - Bloomsbury Publishing PLC, the publisher of Harry Potter book series, said Chief Executive Nigel Newton sold 130,000 shares at a price of 234.23 pence per share on the 1.0

Read more
22 May 2018 11:58

Bloomsbury Publishing Says New Year Performance Will Be Ahead Of Views

LONDON (Alliance News) - Bloomsbury Publishing PLC said Tuesday its performance in the new financial year will be "well ahead" of expectations, as it reported increased profit and for to

Read more
15 May 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 16 May C&C GroupFull Year ResultsBurberry GroupFull Year & Year Year 17

Read more
1 May 2018 09:51

Bloomsbury Publishing Buys Academic Firm IBT Tauris For GBP5.8 Million

LONDON (Alliance News) - Bloomsbury Publishing PLC said Tuesday it acquired academic publishing firm IBT Tauris & Co Ltd for GBP5.8 million in cash.Harry Potter-publisher Bloomsbury pay

Read more
19 Apr 2018 12:57

Bloomsbury Publishing Appoints Conde Nast Executive New Finance Head

LONDON (Alliance News) - Bloomsbury Publishing PLC said Thursday it has appointed Penny Scott-Bayfield as its new finance director from mid July.Scott-Bayfield will replace incumbent Wendy

Read more
27 Mar 2018 13:57

Reuters Health News Summary

Following is a summary of current health news briefs. Severely elevated cholesterol often goes untreated Many patients with dangerously high cholesterol or a genetic predisposition a

Read more
27 Mar 2018 13:57

Reuters Health News Summary

Following is a summary of current health news briefs. Severely elevated cholesterol often goes untreated Many patients with dangerously high cholesterol or a genetic predisposition a

Read more
26 Mar 2018 21:56

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.